Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Current Alzheimer Research
|
October 30, 2015
Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice
Sumit Sarkar, James Raymick, Balmiki Ray, et al.
Neuroscience Letters
|
July 21, 2018
Identification of altered microRNAs in serum of a mouse model of Parkinson's disease
Hector Rosas-Hernandez, Srinivasulu Chigurupati, James Raymick, et al.
Current Neurovascular Research
|
November 27, 2013
Systemic administration of fluoro-gold for the histological assessment of vascular structure, integrity and damage
John F Bowyer, Karen M Tranter, Sumit Sarkar, et al.
Current Alzheimer Research
|
May 1, 2013
Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP/PSI mouse model of Alzheimer's disease
Yi-Hong Zhang, James Raymick, Sumit Sarkar, et al.
Current Neurovascular Research
|
November 27, 2013
Neurovascular changes in acute, sub-acute and chronic mouse models of Parkinson's disease
Sumit Sarkar, James Raymick, Dushyant Mann, et al.
Current Alzheimer Research
|
February 21, 2014
K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice
Yi-Hong Zhang, Dushyant Mann, James Raymick, et al.
Neurotoxicology
|
July 28, 2014
Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model
Sumit Sarkar, Srinivasulu Chigurupati, James Raymick, et al.
Nutritional Neuroscience
|
December 21, 2020
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease
Elvis Cuevas, Susan Burks, James Raymick, et al.
Experimental Neurology
|
May 7, 2016
Corrigendum to "Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity", [Exp. Neurol. 273 (2015), 151-160]
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Experimental Neurology
|
August 17, 2015
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Current Alzheimer Research
|
October 30, 2015
Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice
Sumit Sarkar, James Raymick, Balmiki Ray, et al.
Neuroscience Letters
|
July 21, 2018
Identification of altered microRNAs in serum of a mouse model of Parkinson's disease
Hector Rosas-Hernandez, Srinivasulu Chigurupati, James Raymick, et al.
Current Neurovascular Research
|
November 27, 2013
Systemic administration of fluoro-gold for the histological assessment of vascular structure, integrity and damage
John F Bowyer, Karen M Tranter, Sumit Sarkar, et al.
Current Alzheimer Research
|
May 1, 2013
Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP/PSI mouse model of Alzheimer's disease
Yi-Hong Zhang, James Raymick, Sumit Sarkar, et al.
Current Neurovascular Research
|
November 27, 2013
Neurovascular changes in acute, sub-acute and chronic mouse models of Parkinson's disease
Sumit Sarkar, James Raymick, Dushyant Mann, et al.
Current Alzheimer Research
|
February 21, 2014
K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice
Yi-Hong Zhang, Dushyant Mann, James Raymick, et al.
Neurotoxicology
|
July 28, 2014
Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model
Sumit Sarkar, Srinivasulu Chigurupati, James Raymick, et al.
Nutritional Neuroscience
|
December 21, 2020
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease
Elvis Cuevas, Susan Burks, James Raymick, et al.
Experimental Neurology
|
May 7, 2016
Corrigendum to "Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity", [Exp. Neurol. 273 (2015), 151-160]
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Experimental Neurology
|
August 17, 2015
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
Erez Eitan, Emmette R Hutchison, Nigel H Greig, et al.
Page
of 4